| The currently available mappings and condition-specific preference-based instruments can result in incremental cost-effectiveness ratios at least 20 % higher than those based on EQ-5D in a lifetime model for multiple sclerosis (MS). |
| Health technology assessment bodies should be aware that the different instruments to measure utilities in MS can result in rather different outcomes when applied in cost-utility analyses. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.